Evidence map›Paper›PMID 34783825›Full record

ArticleJAMA network open2021

Association of Retinal Nerve Fiber Layer Thickness, an Index of Neurodegeneration, With Depressive Symptoms Over Time.

Frank C T van der Heide, Indra L M Steens, Anouk F J Geraets, Yuri D Foreman, Ronald M A Henry, Abraham A Kroon, Carla J H van der Kallen, Thomas T van Sloten, Pieter C Dagnelie, Martien C J M van Dongen and 11 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Retinal sublayer changes in cases with Alzheimer's disease and depression.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Frank C T van der HeideCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Indra L M SteensCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Anouk F J GeraetsCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Yuri D ForemanCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Ronald M A HenryCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Abraham A KroonCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Carla J H van der KallenCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Thomas T van SlotenCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Pieter C DagnelieCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Martien C J M van DongenCare and Public Health Research Institute, Maastricht University, the Netherlands.
Simone J P M EussenCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Tos T J M BerendschotUniversity Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands.
Jan S A G SchoutenDepartment of Ophthalmology, Canisius-Wilhelmina Ziekenhuis Nijmegen, the Netherlands.
Carroll A B WebersUniversity Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands.
Marleen M J van GreevenbroekCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Anke WesseliusDepartment of Complex Genetics and Epidemiology, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Annemarie KosterCare and Public Health Research Institute, Maastricht University, the Netherlands.
Nicolaas C SchaperCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Miranda T SchramCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Seb KöhlerDepartment of Psychiatry and Neuropsychology, Maastricht University Medical Center+, Maastricht, the Netherlands.
Coen D A StehouwerCardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University, the Netherlands.
Maastricht University · NLCanisius-Wilhelmina Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Whether neurodegeneration contributes to the early pathobiology of late-life depression remains incompletely understood. Objective: To investigate whether lower retinal nerve fiber layer (RNFL) thickness, a marker of neurodegeneration, is associated with the incidence of clinically relevant depressive symptoms and depressive symptoms over time. Design, Setting, and Participants: This is a population-based cohort study from the Netherlands (The Maastricht Study) with baseline examination between 2010 and 2020 and median (IQR) follow-up of 5.0 (3.0-6.0) years. Participants were recruited from the general population. Individuals with type 2 diabetes were oversampled by design. Data analysis was performed from September 2020 to January 2021. Exposures: RNFL, an index of neurodegeneration, assessed with optical coherence tomography. Main Outcomes and Measures: Depressive symptoms were assessed with the Patient Health Questionnaire (PHQ)-9 (continuous score, 0-27) at baseline and over time via annual assessments. The presence of clinically relevant depressive symptoms was defined as a PHQ-9 score of 10 or higher. Results: We used data from 4934 participants with depressive symptoms over time (mean [SD] age, 59.7 [8.4] years; 2159 women [50.8%]; 870 had type 2 diabetes [20.5%]). Lower RNFL thickness was associated with higher incidence of clinically relevant depressive symptoms (per 1 SD, hazard ratio 1.11; 95% CI, 1.01-1.23) and more depressive symptoms over time (per 1 SD, rate ratio, 1.04; 95% CI, 1.01-1.06), after adjustment for demographic, cardiovascular, and lifestyle factors. Conclusions and Relevance: The findings of this study suggest that lower RNFL thickness is associated with higher incidence of clinically relevant depressive symptoms and more depressive symptoms over time. Hence, neurodegeneration may be associated with the early pathobiology of late-life depression.

Indexed as

AdultAgedCohort StudiesDepressive DisorderDiabetes Mellitus, Type 2FemaleHumansIncidenceMaleMiddle AgedNerve FibersNetherlandsNeurodegenerative DiseasesRetina

Identifiers

PMID34783825
PMCPMC8596200
OpenAlexW3213628900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.